Clinical Trials Logo

Filter by:
NCT ID: NCT06051071 Recruiting - Stress Clinical Trials

Home-based Stimulation to Promote Resilience

Start date: September 1, 2023
Phase: N/A
Study type: Interventional

Background: Non-invasive brain stimulation showed to be effective in reduce stress related cognitive and mental-health consequences. Thanks to technological advances these devices are now very easy to use and suitable to hoe-based self-administration. Objective: Conduct a home-based and tele-supervised non-invasive brain stimulation intervention to modulate the expression of resilience brain networks. Methods: Transcranial direct current stimulation will be used duringa tele-supervised home-based stimulation intervention to promote the expression of brain resilience networks. Expected results: The present project should provide critical new knowledge and evidences of the feasibility and impact of modulating brain resilience networks in terms of its effects on mental health of participants, including the possibility to implement future self-administered, home-based interventions.

NCT ID: NCT06051032 Recruiting - Clinical trials for Pulmonary Embolism and Thrombosis

Compative Study of PE in Thrombosed AVF After Balloon Thrombectomy vs. Thromboaspiration.

Start date: July 21, 2023
Phase: N/A
Study type: Interventional

The goal of this multicentric clinical trial is to compare the incidence of pulmonary thromboembolism (PTE), assessed through AngioCT, in the endovascular treatment of acute thrombosis in native and prosthetic arteriovenous fistulas (AVF). The main questions it aims to answer are: - What is the difference in the incidence of pulmonary thromboembolism (PTE) assessed by AngioCT in endovascular treatment of acute thrombosis of native and prosthetic arteriovenous fistulas using balloon thrombectomy versus thromboaspiration systems? - What is the primary patency rate of arteriovenous fistulas treated with balloon thrombectomy versus thromboaspiration systems? - What is the clinical success rate in the treatment of arteriovenous fistulas using balloon thrombectomy compared to thromboaspiration systems? - What are the costs associated with the different thrombectomy techniques in the treatment of arteriovenous fistulas? Participants will be underwent to balloon thrombectomy versus thromboaspiration systems. Researchers will compare the patients treated with balloon thrombectomy and thromboaspiration systems to see if the incidence of PE is comparable and to evaluate the primary and secondary patency rates of both thrombectomy techniques, the clinical technical success rate, and the costs associated with each technique.

NCT ID: NCT06050928 Recruiting - Clinical trials for Chronic Inducible Urticaria

Phase 1b, Open-Label Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Chronic Inducible Urticaria

CALM-CIndU
Start date: August 30, 2023
Phase: Phase 1
Study type: Interventional

This phase 1b trial will evaluate the effects of EP262 in subjects with Chronic Inducible Urticaria (CIndU), including symptomatic dermographism and cold urticaria.

NCT ID: NCT06050421 Recruiting - Anorexia Nervosa Clinical Trials

Radically Open Dialectical Behaviour Therapy in Patients With Anorexia Nervosa

RODBT-AN
Start date: June 22, 2023
Phase: N/A
Study type: Interventional

Randomized controlled clinical trial to evaluate the efficacy of "Radically Open Dialectical Behaviour Therapy" in patients with eating disorders: a proof-of-concept study.

NCT ID: NCT06049992 Recruiting - Clinical trials for Left Bundle-Branch Pacing

STylet-driven vs. LumenlEss Lead in Left-Bundle-Branch Pacing

STYLE-LBBP
Start date: September 21, 2023
Phase: N/A
Study type: Interventional

The STYLE-LBBP study aims to compare the efficacy and safety of left-bundle branch pacing between the two types of available pacing leads: lumenless vs stylet-driven.

NCT ID: NCT06049654 Recruiting - Clinical trials for Aortic Valve Stenosis

Comparison of Allegra vs Sapien Transcatheter Aortic Valves in Valve-In-Valve Indication

Start date: February 1, 2024
Phase: N/A
Study type: Interventional

The VIVALL-2 study is a randomized trial to compare the self-expandable supra-annular Allegra and the balloon-expandable intra-annular Edwards transcatheter valve systems in patients with degenerated biological aortic surgical valve.

NCT ID: NCT06049589 Active, not recruiting - Periodontitis Clinical Trials

Therapeutic Application of Coconut Oil in Oral Health

Start date: November 1, 2022
Phase: N/A
Study type: Interventional

The scientific literature has verified that coconut oil has properties that open perspectives for its application in order to maintain oral health and, in particular, for the treatment of different oral pathologies. Thus, the purpose of this project is summarized in the following objectives: 1. Determine in vitro the biocompatibility of coconut oil. 2. Determine in vivo the clinical effect of coconut oil as an adjunct treatment for periodontal disease.

NCT ID: NCT06049407 Recruiting - Emotion Regulation Clinical Trials

Intervention on Socio-emotional Development and Well-being Through ICTs in Early Adulthood

EMOWELL
Start date: September 1, 2021
Phase: N/A
Study type: Interventional

emoWELL is a serious game, that is, a video game designed to inform and train in skills and competencies in a more dynamic way. emoWELL focuses on understanding and developing healthy emotional regulation strategies to improve well-being.

NCT ID: NCT06049147 Completed - Clinical trials for Safety and Pharmacokinetic

Study to Assess the Safety and Tolerability of MBF-015 in Healthy Young Volunteers

Start date: July 7, 2021
Phase: Phase 1
Study type: Interventional

This is a single center, randomised, double blind, placebo controlled clinical study to assess the safety and tolerability of MBF-015 in healthy volunteers.This clinical phase I trial is divided in two stages and involves, first, a single ascending dose (SAD) study in healthy young male volunteers and then a multiple ascending dose (MAD) study in healthy young men and woman. MBF-118 is developed for the treatment of multiple sclerosis.

NCT ID: NCT06049017 Recruiting - Colitis, Ulcerative Clinical Trials

A Study of JNJ-77242113 in Participants With Moderately to Severely Active Ulcerative Colitis

ANTHEM-UC
Start date: October 9, 2023
Phase: Phase 2
Study type: Interventional

The purpose of this study is to evaluate the safety and effectiveness of JNJ-77242113 compared with placebo in participants with moderately to severely active ulcerative colitis.